The Mechanical,Physiological and Therapeutic Effects of Eccentric Exercise Combined With Extracorporeal Shockwave Therapy in Athletes With Patellar Tendinopathy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04650997 |
|
Recruitment Status :
Completed
First Posted : December 3, 2020
Last Update Posted : December 3, 2020
|
Sponsor:
The Hong Kong Polytechnic University
Information provided by (Responsible Party):
The Hong Kong Polytechnic University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
Patellar tendinopathy is one of the most common injuries in jumping athletes. Changes in mechanical and physiological properties of tendon are the two proposed forms of pathogenesis. The efficacy of eccentric exercise when applied alone and combined with extrocoporeal shockwave therapy had been reported; however, the underlying treatment mechanisms of pain and dysfunction are not clear. This project aimed to explore the mechanical, physiological and therapeutic effects of eccentric exercise when applied as a single treatment and as an adjunct to extracorporeal shockwave therapy.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Patellar Tendinopathy | Behavioral: Eccentric exercise | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 43 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | The Mechanical,Physiological and Therapeutic Effects of Eccentric Exercise Combined With Extracorporeal Shockwave Therapy in Athletes With Patellar Tendinopathy |
| Actual Study Start Date : | February 16, 2011 |
| Actual Primary Completion Date : | January 1, 2014 |
| Actual Study Completion Date : | January 1, 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Combined
12 weeks eccentric exercise combined with 6 sessions of extracorporeal shockwave therapy in the initial 6 weeks
|
Behavioral: Eccentric exercise
Knee eccentric exercise with sham or focused extrocorporeal shockwave therapy for 12 weeks
Other Name: Extracoporeal shockwave therapy (Minilith SL1, Storz Medical) |
|
Sham Comparator: Exercise
12 weeks eccentric exercise combined with 6 sessions of sham extracorporeal shockwave therapy in the initial 6 weeks
|
Behavioral: Eccentric exercise
Knee eccentric exercise with sham or focused extrocorporeal shockwave therapy for 12 weeks
Other Name: Extracoporeal shockwave therapy (Minilith SL1, Storz Medical) |
Primary Outcome Measures :
- Tendon stress in pascals at baseline [ Time Frame: Before intervention ]Tendon stress measured by ultrasonography and dynamometry
- Change of tendon stress in pascals at 12 weeks [ Time Frame: 12 weeks ]Tendon stress measured by ultrasonography and dynamometry
- Change of tendon stress in pascals at 16 weeks [ Time Frame: 16 weeks ]Tendon stress measured by ultrasonography and dynamometry
- Tendon vascularity index as percentage at baseline [ Time Frame: Before intervention ]Tendon vascularity measured by power doppler ultrasonography
- Change of tendon vascularity index as percentage at 12 weeks [ Time Frame: 12 weeks ]Tendon vascularity measured by power doppler ultrasonography
- Change of tendon vascularity index as percentage at 16 weeks [ Time Frame: 16 weeks ]Tendon vascularity measured by power doppler ultrasonography
Secondary Outcome Measures :
- Tendon related pain on visual analogy scale at baseline [ Time Frame: Before intervention ]Maximal intensity of self-perceived pain in the past 7 days, pain during single-leg declined-squat test
- Change of tendon related pain on visual analogy scale at 12 weeks [ Time Frame: 12 weeks ]Maximal intensity of self-perceived pain in the past 7 days, pain during single-leg declined-squat test
- Change of tendon related pain on visual analogy scale at 16 weeks [ Time Frame: 16 weeks ]Maximal intensity of self-perceived pain in the past 7 days, pain during single-leg declined-squat test
- Tendon related dysfunction by questionnaire at baseline [ Time Frame: Before intervention ]Victorian Institute of Sport Assessment Questionnaire - Patellar Tendon
- Change of tendon related dysfunction by questionnaire at 12 weeks [ Time Frame: 12 weeks ]Victorian Institute of Sport Assessment Questionnaire - Patellar Tendon
- Change of tendon related dysfunction by questionnaire at 16 weeks [ Time Frame: 16 weeks ]Victorian Institute of Sport Assessment Questionnaire - Patellar Tendon
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Competitive athletes
- Pain at the inferior pole of the patella with training for at least 3 months
- Tenderness at the inferior pole of the patella on palpation
Exclusion Criteria:
- Patellofemoral pain syndrome, fat pad irritations, meniscus injury, osteoarthritis, rheumatoid arthritis or infections
- History of fracture over lower limbs and inflammatory myopathies
- Cortisone injuection and other interventions within 3 months
- Contraindication to extracorporeal shockwave therapy
No Contacts or Locations Provided
| Responsible Party: | The Hong Kong Polytechnic University |
| ClinicalTrials.gov Identifier: | NCT04650997 |
| Other Study ID Numbers: |
HSEARS20110215003 |
| First Posted: | December 3, 2020 Key Record Dates |
| Last Update Posted: | December 3, 2020 |
| Last Verified: | February 2011 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | No plan |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
Additional relevant MeSH terms:
|
Tendinopathy Muscular Diseases Musculoskeletal Diseases Tendon Injuries Wounds and Injuries |

